SCHEMBL16692729

SCHEMBL16692729

O=C(Nc1ccc(S)cc1)c1ccsc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.70
▸ NPC1 O15118 2/20 0.65
▸ RAB9A P51151 2/20 0.65
▸ KCNK3 O14649 1/20 0.56
▸ KCNK9 Q9NPC2 1/20 0.56
▸ HDAC1 Q13547 1/20 0.55
▸ KMT2A Q03164 2/20 0.50
▸ GRM4 Q14833 1/20 0.50
▸ CES2 O00748 1/20 0.47
▸ CES1 P23141 1/20 0.47
▸ LCK P06239 1/20 0.46
▸ FYN P06241 1/20 0.46
▸ DAO P14920 1/20 0.46
▸ NAMPT P43490 1/20 0.45
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ AXL P30530 1/20 0.44
▸ MAPK14 Q16539 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31198184 0.84 HPGD (0.72) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL27652929 0.83 HPGD (0.76) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL7715873 0.83 HPGD (0.70) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL15070509 0.83 HPGD (0.70) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL6623847 0.82 HPGD (1.00) HPGDNPC1RAB9AKCNK3KCNK9
Hydrochloric Acid SCHEMBL27518063 0.81 HPGD (0.68) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL21114830 0.80 HPGD (0.66) HPGDNPC1RAB9AKCNK3KCNK9
SCHEMBL8826894 0.79 NPC1 (0.63) NPC1RAB9AKMT2AGAAMEN1
SCHEMBL8537614 0.79 NPC1 (0.63) NPC1RAB9AKMT2AGAAMEN1
SCHEMBL18010168 0.79 HPGD (0.64) HPGDNPC1RAB9AKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290525-B1 METHOD FOR SCREENING DRUG AND THERAPEUTIC TARGET USED FOR TREATING ALZHEIMER'S DISEASE JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD (CN) 2022-02-23 — — EP disclosed
EP-3290525-A1 METHOD FOR SCREENING DRUG AND THERAPEUTIC TARGET USED FOR TREATING ALZHEIMER'S DISEASE Jiangsu Nuo-Beta Pharmaceutical Technology Co., Ltd. (CN) 2018-03-07 — — EP disclosed
EP-3290514-A1 APPLICATION OF PI4KIII PROTEIN AND RELATED MEMBRANE PROTEIN COMPLEX IN TREATING ALZHEIMER'S DISEASE Jiangsu Nuo-Beta Pharmaceutical Technology Co., Ltd. (CN) 2018-03-07 — — EP disclosed
US-9682931-B2 Aryloyl(oxy or amino)pentafluorosulfanylbenzene compound, pharmaceutically acceptable salt thereof, and prodrugs thereof UBE INDUSTRIES, LTD. (JP) 2017-06-20 — — US disclosed
WO-2015064764-A1 ARYLOYL(OXY OR AMINO)PENTAFLUOROSULFANYLBENZENE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PRODRUGS THEREOF 宇部興産株式会社 2015-05-07 — — WO disclosed
Send feedback